Your Navigation:PCAR > Abstract
Search pcar
Pharmaceutical Care and Research: 2018; 18(3):233-234
DOI: 10.5428/pcar20180321
Pharmaceutical care for a patient with refractory ulcerative colitis complicated with Clostridium difficile infection
1. LIU Tao(a
2. YE YinMei(a
Welcome to PCAR! You are the number 512 reader of this article!
Please cite this article as:
LIU Tao,YE YinMei,. Pharmaceutical care for a patient with refractory ulcerative colitis complicated with Clostridium difficile infection[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(3): 233-234.
1. Ricciardi R,Ogilvie J W Jr,Roberts P L,et al.Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases[J].Dis Colon Rectum,2009,52(1):40-45.
2. Group of Inflammatory Bowel Diseases,Branch of Digestiology,Chinese Medical Association.Consensus on the diagnosis and treatment of inflammatory bowel diseases(2012,Guangzhou)[J].Chin J Intern Med,2012,51(10):818-831.In Chinese.
3. Musa S,Thomson S,Cowan M,et al.Clostridium difficile infection and inflammatory bowel diseases[J].Scand J Gastroenterol,2010,45(3):261-272.
4. Powell N,Jung S E,Krishnan B.Clostridium difficile infection and inflammatory bowel diseases:a marker for disease extent?[J].Gut,2008,57(8):1183-1184.
5. Trubiano J A,Cheng A C,Korman T M,et al.Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand[J].Intern Med J,2016,46(4):479-493.
6. Negrón M E,Rezaie A,Barkema H W,et al. Ulcerative colitis patients with Clostridium difficile are at increased risk of death,colectomy,and postoperative complications:a population-based inception cohort study[J].Am J Gastroenterol,2016,111(6):691-704.
7. JIA TianYe,TANG YiWei,QU Fen.Key points of American guidelines for the diagnosis and treatment of Clostridium difficile infection[J].Infect Dis Inf,2015,28(4):193-196.In Chinese with English abstract.
8. Wombwell E,Chittum M E,Leeser K R.Inpatient proton pump inhibitor administration and hospital-acquired Clostridium difficile infection:evidence and possible mechanism[J].Am J Med,2018,131(3):244-249.
9. Surawicz C M,Brandt L J,Binion D G,et al.Guidelines for diagnosis,treatment, and prevention of Clostridium difficile infections[J].Am J Gastroenterol,2013,108(4):478-498.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330